Introduction: To assess cognitive impairment, self-awareness is an important issue. The Ascertain Dementia 8 questionnaire (AD8) is a brief observation checklist for detecting mild cognitive impairment (MCI) and dementia. After analyzing the reliability and validity of a self-reported Japanese version of the AD8 (AD8-J), we compared self- and informant-reported versions of the AD8-J. Methods: A total of 93 community residents aged 75 years or older living in Wakuya, Northern Japan, agreed to participate in this study; 35 were rated as Clinical Dementia Rating (CDR) 0 (healthy), 46 as CDR 0.5 (defined herein as MCI), and 12 as CDR 1 or above (dementia, confirmed by the DSM-IV). We examined the reliability and validity using a receiver operating characteristic (ROC) curve. We analyzed the differences between self-reported and informant-reported AD8-J using a repeated measures ANOVA. Results: The self-reported AD8-J showed a satisfactory reliability (i.e., Cronbach coefficient, α = 0.71; Guttman split half method coefficient = 0.60). For CDR 0 vs. CDR 0.5 or above, the area under the ROC curve was 0.74 and the cutoff score was 1/2, with a sensitivity of 70.7% and a specificity of 65.7%. Analysis of the subscores of AD8 suggested that, from the early stage of dementia, the subjects showed a subjective decline in memory and interest in hobbies/activities, as well as problems with judgment. Conclusion: It is suggested that the self-reported AD8-J was effective in detecting MCI and dementia. We could use it for detecting MCI and dementia, including in those living alone, in the primary health checkup.

The stage of Clinical Dementia Rating (CDR) 0.5 is the borderline condition between health and dementia [1]. Previously, we reported that the prevalence of amnestic mild cognitive impairment (MCI) was 4.9%, whereas that of CDR 0.5 was 30.2% [2]; thus we considered that the concept of CDR 0.5 was better as a screen for participants with prodromal dementia than amnestic MCI.

However, the scoring of informant-based instruments such as the CDR is dependent on the reliability of the family or caregiver [3]. According to information from the government, in 2016 the number of 1-person households with persons aged 65 or older was 27% [4]. For elderly people who live alone, we could not use an informant rating assessment.

Alternative to an informant-based approach, there are performance-based tests and self-reported tests. The former include neuropsychological tests such as the Mini-Mental State Examination (MMSE) [5]; however, these tests may be difficult to use to evaluate recent changes [3].

Self-rating scales were not so frequently used, since many dementia patients have a lack of awareness or denial of cognitive deficits (cognitive anosognosia). Awareness of cognitive impairments varies between individuals, with some patients offering reliable accounts of cognitive change and others failing to estimate symptoms [3, 6]. Meanwhile, some patients with dementia have been reported to be able to self-rate the physical and psychological symptoms such as depression [7].

There are several self-rating tests for detecting MCI and dementia, such as the Ascertain Dementia 8 questionnaire (AD8) [8], the Self-Administered Gerocognitive Examination (SAGE) [9], the 64-item Memory Functioning Questionnaire [10, 11], and the Self-Administered Dementia Checklist [12].

The AD8 consists of 8 short questions about memory complaints. Galvin et al. [8] reported the use of the self-reported AD8 as an alternative scale of informant-reported AD8. The SAGE was developed as a 10- to 15-min self-administered cognitive assessment tool, but it was affected by the individual’s low educational attainment and visual impairment [3, 9]. The 64-item Memory Functioning Questionnaire consisted of 64 items of everyday memory functioning [10, 11], but it was too long for general use.

The self-reported AD8 was reported to have good sensitivity and specificity for distinguishing MCI and dementia patients from healthy populations [8]. Since the self-reported AD8 includes objective questions about everyday functional activities in a nonthreatening fashion [8], it might be suitable for assessing MCI and dementia.

Since there were no previous studies of a Japanese version of the self-reported AD8 (Self-AD8-J), the first aim of this study was to establish its reliability and validity. The second aim was to compare self- and informant-reported versions to discuss self-awareness of cognitive impairment.

Participants

From December 2017 to March 2018, one hundred residents (35 men and 58 women) aged 75 years or older living in Wakuya, Northern Japan, agreed to participate in this study. Ninety-three participants completed the Self-AD8-J and the Japanese version of the informant-reported AD8 (Info-AD8-J); 35 (11 men and 24 women) were rated as CDR 0 (healthy), 46 (19 men and 27 women) as CDR 0.5 (questionable dementia or very mild dementia), and 12 (5 men and 7 women) as CDR 1 or higher (dementia; Table 1).

Table 1.

Demographics of the participants

Demographics of the participants
Demographics of the participants

We excluded 7 participants due to incomplete data sets. All subject with CDR 1 or higher met the criteria for a dementia diagnosis with the DSM-IV [13]. We also conducted clinical examinations and neuropsychological tests. With regard to demographic data, significant differences were found among the 3 CDR groups in terms of age, educational level, and MMSE scores using a one-way ANOVA and Bonferroni post hoc group comparisons; p < 0.05 was considered statistically significant.

Assessments

Ascertain Dementia 8 Questionnaire

The informant-reported AD8 [8, 14, 15] is a brief and sensitive informant-based assessment for detection of participants with MCI and dementia in a community. The informant-reported AD8 consists of 8 short questions about judgement and memory complaints, with 3 answer options each, and the estimated time is 2–3 min. The 3 answer options of the AD8 include: (1) yes (change), (2) no (no change), and (3) N/A (do not know).

In the informant-reported AD8, the cutoff score of the original version for screening for MCI and dementia was 1/2, with a sensitivity of 84% and a specificity of 93% [8]. Meanwhile, the cutoff score of the Info-AD8-J for screening for dementia was 1/2, with a sensitivity of 88% and a specificity of 68% in a community-based study [16].

In the self-reported AD8, the cutoff score of the original version for screening for MCI and dementia was 0/1, with a sensitivity of 80% and a specificity of 59% [8].

We used the Self-AD8-J and the Info-AD8-J [16].

Clinical Dementia Rating

A clinical team comprised of skilled physicians (2 neurologists and 2 psychiatrists) and public health nurses determined the CDR for each participant [1, 17] and were blinded to the cognitive test results. They used the Japanese version of the questionnaire of the CDR work sheet [18]. The CDR contains the following 6 domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Before the interviews with the physicians, the public health nurses visited the participants’ homes to evaluate their daily activities. Finally, with reference to the information provided by the family members, the CDR for each of the participants was determined at a joint meeting of the physicians and public health nurses. One author (K.M.) was certified as a CDR rater by the Knight Alzheimer’s Disease Research Center’s Memory and Aging Project at the Washington University School of Medicine.

Mini-Mental State Examination

We used the MMSE [5] to assess general cognitive functions. The MMSE consists of orientation, registration, serial 7s, recall, naming, repetition, comprehension, reading, writing, and drawing. Scores on the MMSE range from 0 (poor) to 30 (good).

Analyses

Reliability of the Self-AD8-J

We used the Cronbach coefficient α and the Guttman split half method coefficient for reliability analysis of the Self-AD8-J.

Validity of Self-AD8-J and the Info-AD8-J

We calculated the area under the curve (AUC) of the receiver operating characteristic (ROC) curve and its 95% CI for the Self-AD8-J score, the Info-AD8-J, and the MMSE (CDR 0 vs. CDR 0.5 or higher [CDR 0.5+]). Participants with a CDR of 0.5+ included those with a CDR of 0.5 (n = 46) and those with a CDR of 1+ (n = 12). Sensitivity, specificity, positive predictive values and negative predictive values, as well as likelihood ratios, were calculated with standard formulas. We compared the AUC of Self-AD8-J and Info-AD8-J scores with that of the MMSE using paired Z-score analysis [19].

Differences between the Self-AD8-J and the Info-AD8-J

We analyzed the differences between the Self-AD8-J and the Info-AD8-J among the 3 CDR groups using a repeated measures ANOVA (2 rater effects [Self-AD8-J vs. Info-AD8-J] × 3 CDR effects [CDR 0 vs. CDR 0.5 vs. CDR 1+]) with a Bonferroni post hoc test (significance level: p < 0.05). When there was a significant interaction between these effects, we used the t test for rater effect and a one-way ANOVA with a Bonferroni post hoc test for CDR effect (significance level: p < 0.05).

We used IBM SPSS statistics version 22 software (IBM, Corp., Armonk, NY, USA) for all statistical analyses in this study.

Reliability of the Self-AD8-J

The Cronbach α coefficient was 0.71 (range 0.65–0.72), and the Guttman split half method coefficient was 0.60 (group A: items 1, 2, 3, and 4; group B: items 5, 6, 7, and 8).

Validity of the Self-AD8-J and the Info-AD8-J

Figure 1 shows the ROC curves of the Self-AD8-J and the Info-AD8-J and the MMSE.

Fig. 1.

ROC of Self-AD8-J and the Info-AD8-J and the MMSE: CDR 0 vs. CDR 0.5 or higher. Thick line: ROC of the Self-AD8-J. Dashed line: ROC of the Info-AD8-J. Thin line: ROC of the MMSE.

Fig. 1.

ROC of Self-AD8-J and the Info-AD8-J and the MMSE: CDR 0 vs. CDR 0.5 or higher. Thick line: ROC of the Self-AD8-J. Dashed line: ROC of the Info-AD8-J. Thin line: ROC of the MMSE.

Close modal

Table 2 shows the ROC curve and cutoff scores and diagnostic accuracy, sensitivity, and specificity of the Self-AD8-J and the Info-AD8-J.

Table 2.

ROC curve and diagnostic accuracy of the Self-AD8-J and the Info-AD8-J

ROC curve and diagnostic accuracy of the Self-AD8-J and the Info-AD8-J
ROC curve and diagnostic accuracy of the Self-AD8-J and the Info-AD8-J

Differences between the Self-AD8-J and the Info-AD8-J

Table 3 shows the results of the mean total and subscores of the Self-AD8-J and the Info-AD8-J among the CDR groups. The total score and those of items 2, 3, 7, and 8 showed significant interactions between rater and CDR effects.

Table 3.

Self-AD8-J and Info-AD8-J scores

Self-AD8-J and Info-AD8-J scores
Self-AD8-J and Info-AD8-J scores

Total score: rater and CDR effects with an interaction.

  • Rater effect: the Self-AD8-J score was severer than the Info-AD8-J score in the CDR 0.5 group.

  • CDR effect: the Self-AD8-J scores of the CDR 0.5 and 1+ groups were severer than that of the CDR 0 group. The Info-AD8-J score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 1 (problems with judgment): rater and CDR effects, but no interaction.

  • Rater effect: the Self-AD8-J score was severer than the Info-AD8-J score.

  • CDR effect: the score of the CDR 1+ group was severer than that of the CDR 0 group.

Item 2 (reduced interest in hobbies/activities): rater and CDR effects with an interaction.

  • Rater effect: the Self-AD8-J score was severer than the Info-AD8-J score in the CDR 0.5 group.

  • CDR effect: the Self-AD8-J scores of the CDR 0.5 and 1+ groups were severer than that of the CDR 0 group. The Info-AD8-J score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 3 (repeats questions, stories, or statements): CDR effect with an interaction, but no rater effect.

  • Rater effect: the Self-AD8-J score was severer than the Info-AD8-J score in the CDR 0.5 group.

  • CDR effect: there was no difference among the 3 groups in terms of the Self-AD8-J score. The Info-AD8-J score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 4 (trouble learning how to use tools, appliances, or gadgets): no rater or CDR effects with no interaction.

Item 5 (forgets the correct month or year): CDR effect, but no rater effect with no interaction.

  • CDR effect: the score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 6 (difficulty handling complicated financial affairs): CDR effect, but no rater effect with no interaction.

  • CDR effect: the score of CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 7 (difficulty remembering appointments): rater and CDR effects with an interaction.

  • Rater effect: the Info-AD8-J score was severer than the Self-AD8-J score in the CDR 1+ group.

  • CDR effect: there was no difference among the 3 groups in terms of the Self-AD8-J score. The Info-AD8-J score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Item 8 (consistent problems with thinking and/or memory): rater and CDR effects with an interaction.

  • Rater effect: the Self-AD8-J score was severer than the Info-AD8-J score in the CDR 0.5 group.

  • CDR effect: the Self-AD8-J score of the CDR 0.5 group was severer than that of the CDR 0 group. The Info-AD8-J score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups.

Reliability of the Self-AD8-J

Since the previous study reported that Cronbach α values of 0.7–0.8 are regarded as satisfactory [20], we considered that the Self-AD8-J had enough reliability for analysis.

Validity of the Self-AD8-J and the Info-AD8-J

If the cutoff scores of the Self-AD8-J were 0/1, then the sensitivity would be good but the specificity would be poor for detecting MCI and dementia. In contrast, if the cutoff level of the Self-AD8-J were 1/2, then the sensitivity would be lower and the specificity higher than the cutoff level of 0/1 in the study of Galvin et al. [20]. Our results regarding the Self-AD8-J suggest that the “subjective” memory complaints of MCI participants may be a common feature across cultures (e.g., St. Louis, MO, USA, and Wakuya, Japan).

If the cutoff scores of the Info-AD8-J were 0/1, then the sensitivity and the specificity would be poor for detecting MCI and dementia. In contrast, if the cutoff were 1/2, then the specificity would be higher. The town of Wakuya promotes the longevity of elderly people, and we have organized the Strategy Meeting on Dementia Prevention with town officials. We thought that our education effort should be gradually widespread so as to increase the ability to detect early dementia in the community through observation.

Differences between the Self-AD8-J and the Info-AD8-J

There was an interaction in the total and items 2, 3, 7, and 8. In item 2, CDR 0.5 participants had a subjective decline in “interest in hobbies/activities.” In a previous study, elderly people subjectively felt a reducing of QOL when they actually had objective home and hobby impairment [21]. The subjective decline in hobbies and activities may be an assessment point for early detection of MCI and dementia.

In items 3 and 8, i.e., “unneeded repetition of questions” and “consistent problems with thinking and/or memory,” some CDR 0.5 participants had subjective memory complaints; however, their family members might not have recognize mild cognitive changes.

In item 7, clinically we know that “forgetting of an appointment” for a hospital visit is an objective symptom of early-stage dementia. Dementia patients may have cognitive anosognosia with regard to their severe cognitive impairments [3, 21], and their caregivers may overestimate their symptoms.

In item 1, i.e., “problems with judgment,” the score on the Self-AD8-J was severer than those on the Info-AD8-J. The score of the CDR 1+ group was severer than those of the CDR 0 and 0.5 groups for item 5, i.e., “forgets the correct month or year,” and item 6, i.e., “difficulty handling complicated financial affairs.”

There were no significant rater or CDR effects on item 4, i.e., “trouble learning how to use tools, appliances, or gadgets” in this study. About 30% of the healthy elderly had difficulty learning how to use these appliances since newer-model home electrical appliances tend to have a high degree of performance and complexity.

Limitations

This study has several limitations. The first limitation is that our sample size of patients with dementia was small. We could not conduct a test-retest reliability analysis since this study had a community-based design. We used only the MMSE as a neuropsychological test for validity analysis. It may be difficult to detect MCI in healthy elderly populations with a high educational attainment, as in this study.

This study indicated that the Self-AD8-J had a good sensitivity for detecting MCI and dementia. It is suggested that the Self-AD8-J is superior in detecting MCI and dementia. We could use the Self-AD8-J for detecting MCI and dementia, including in those living alone, in the primary health checkup.

We are grateful to all of the staff in Wakuya, especially the public health nurses, and the staff at the Geriatric Behavioral Neurology Project, Tohoku University New Industry Creation Hatchery Center (NICHe). In particular, we thank Ms. Keiko Chida, Yuriko Kato, and Megumi Kano.

Written informed consent was obtained from each of the participants and their families. This study was approved by the Ethical Committees of the Wakuya government and the Tohoku University Graduate School of Medicine (2014-1-565).

The authors have no conflict of interests to declare.

This work was supported by the Commissioned Research Fund of the City of Wakuya.

M.K.: data analysis and writing of this paper. K.M.: design, direction, and writing of this paper. T.S., K.K., J.T., and K.N.: data collection.

1.
Morris
JC
.
The Clinical Dementia Rating (CDR): current version and scoring rules
.
Neurology
.
1993
Nov
;
43
(
11
):
2412
4
.
[PubMed]
0028-3878
2.
Meguro
K
,
Ishii
H
,
Yamaguchi
S
,
Ishizaki
J
,
Sato
M
,
Hashimoto
R
, et al
Prevalence and cognitive performances of clinical dementia rating 0.5 and mild cognitive impairment in Japan. The Tajiri project
.
Alzheimer Dis Assoc Disord
.
2004
Jan-Mar
;
18
(
1
):
3
10
.
[PubMed]
0893-0341
3.
Galvin
JE
.
Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia
.
Curr Geriatr Rep
.
2018
Mar
;
7
(
1
):
19
25
.
[PubMed]
2196-7865
4.
Cabinet Office Japan [Internet]. Annual Report on the Ageing Society [Summary] FY 2018. The Ageing Society: Current Situation and Implementation Measures FY
2017
. Available from: https://www8.cao.go.jp/kourei/english/annualreport/2018/pdf/c1-1.pdf
5.
Folstein
MF
,
Folstein
SE
,
McHugh
PR
.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
.
J Psychiatr Res
.
1975
Nov
;
12
(
3
):
189
98
.
[PubMed]
0022-3956
6.
Kelleher
M
,
Tolea
MI
,
Galvin
JE
.
Anosognosia increases caregiver burden in mild cognitive impairment
.
Int J Geriatr Psychiatry
.
2016
Jul
;
31
(
7
):
799
808
.
[PubMed]
0885-6230
7.
Yesavage
JA
,
Brink
TL
,
Rose
TL
,
Lum
O
,
Huang
V
,
Adey
M
, et al
Development and validation of a geriatric depression screening scale: a preliminary report
.
J Psychiatr Res
.
1982-1983-1983
;
17
(
1
):
37
49
.
[PubMed]
0022-3956
8.
Galvin
JE
,
Roe
CM
,
Coats
MA
,
Morris
JC
.
Patient’s rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia
.
Arch Neurol
.
2007
May
;
64
(
5
):
725
30
.
[PubMed]
0003-9942
9.
Scharre
DW
,
Chang
SI
,
Murden
RA
,
Lamb
J
,
Beversdorf
DQ
,
Kataki
M
, et al
Self-administered Gerocognitive Examination (SAGE): a brief cognitive assessment Instrument for mild cognitive impairment (MCI) and early dementia
.
Alzheimer Dis Assoc Disord
.
2010
Jan-Mar
;
24
(
1
):
64
71
.
[PubMed]
0893-0341
10.
Gilewski
MJ
,
Zelinski
EM
,
Schaie
KW
.
The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age
.
Psychol Aging
.
1990
Dec
;
5
(
4
):
482
90
.
[PubMed]
0882-7974
11.
Zelinski
EM
,
Gilewski
MJ
,
Anthony-Bergstone
CR
.
Memory Functioning Questionnaire: concurrent validity with memory performance and self-reported memory failures
.
Psychol Aging
.
1990
Sep
;
5
(
3
):
388
99
.
[PubMed]
0882-7974
12.
Ura
C
,
Miyamae
F
,
Sakuma
N
,
Niikawa
H
,
Inagaki
H
,
Ijuin
M
, et al
[Development of a self-administered dementia checklist (SDC) (1): examination of factorial validity and internal reliability]
.
[Article in Japanese]
.
Nippon Ronen Igakkai Zasshi
.
2015
;
52
(
3
):
243
53
.
[PubMed]
0300-9173
13.
American Psychiatric Association
.
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
. 4th ed.
Washington (DC)
:
American Psychiatric Association
;
1994
.
14.
Galvin
JE
,
Roe
CM
,
Powlishta
KK
,
Coats
MA
,
Muich
SJ
,
Grant
E
, et al
The AD8: a brief informant interview to detect dementia
.
Neurology
.
2005
Aug
;
65
(
4
):
559
64
.
[PubMed]
0028-3878
15.
Galvin
JE
,
Roe
CM
,
Xiong
C
,
Morris
JC
.
Validity and reliability of the AD8 informant interview in dementia
.
Neurology
.
2006
Dec
;
67
(
11
):
1942
8
.
[PubMed]
0028-3878
16.
Meguro
K
,
Kasai
M
,
Nakamura
K
;
Kurihara Project members
.
[Reliability and validity of the Japanese version of the AD8]
.
[Article in Japanese]
.
Nippon Ronen Igakkai Zasshi
.
2015
;
52
(
1
):
61
70
.
[PubMed]
0300-9173
17.
Hughes
CP
,
Berg
L
,
Danziger
WL
,
Coben
LA
,
Martin
RL
.
A new clinical scale for the staging of dementia
.
Br J Psychiatry
.
1982
Jun
;
140
(
6
):
566
72
.
[PubMed]
0007-1250
18.
Meguro
K
.
The CDR Scoring Handbook for Early Detection of Dementia
.
Tokyo
:
Igaku-Shoin
;
2008
.
19.
Hanley
JA
,
McNeil
BJ
.
A method of comparing the areas under receiver operating characteristic curves derived from the same cases
.
Radiology
.
1983
Sep
;
148
(
3
):
839
43
.
[PubMed]
0033-8419
20.
Bland
JM
,
Altman
DG
.
Cronbach’s alpha
.
BMJ
.
1997
Feb
;
314
(
7080
):
572
.
[PubMed]
0959-8138
21.
Kasai
M
,
Meguro
K
.
Patients with very mild dementia may confuse objective cognitive impairments with subjective physical health of quality of life: The Tome City Project in Japan
.
Front Psychol
.
2018
Apr
;
9
:
533
.
[PubMed]
1664-1078
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.